George Vlachogiannis, Managing Editor of Cancer Control at Sage, shared a post on LinkedIn:
”Cancer Control reports an Expert Consensus Statement on resectability in stage III non-small cell lung cancer (NSCLC) within resource-limited settings. The consensus was developed by a multidisciplinary panel of Colombian experts following the European Society for Medical Oncology (ESMO) standardized operating procedures.
The panel highlights that selected patients, particularly those with non-bulky, single-station N2 disease, may be candidates for surgery as part of multimodality treatment, while emphasizing individualized decision-making, invasive restaging when appropriate, and multidisciplinary evaluation.
This work is highly relevant for low- and middle-income countries, where access to advanced staging, specialized surgery, and coordinated cancer care may be limited.
By adapting evidence to real-world constraints, the consensus supports more consistent surgical decision-making and aims to improve outcomes and quality of life for patients with locally advanced NSCLC, especially in resource-limited settings.”
Title: Stage III Non-small Cell Lung Cancer Resectability in a Country With Limited Diagnostic and Therapeutic Resources: A Colombian Expert Consensus
Authors: Carlos A. Carvajal, Stella I. Martínez, Diego Pardo, Darwin Padilla, Mauricio Velásquez, Willfredy Castaño, Fernando Alvarado, Ricardo A. Zapata-González, Jairo Zuluaga, Ricardo E. Bruges, Leonardo Rojas, Clarena Zuluaga, Lucia Viola, Ana M. Callejas, Alejandro González-Motta, Eduardo Guerrero, Fernando Rodríguez, José R. Pieschacón, Wagner-Gutiérrez Nicolle, Natalia Sánchez, Andrés F. Cardona
Other Articles Featuring George Vlachogiannis On OncoDaily.